Hepatitis C virus infection in health-care settings: Medical and ethical implications
Journal Title: Annals of Hepatology - Year 2010, Vol 9, Issue 0
Abstract
Hepatitis C is a major public health issue. It infects about 200 million people worldwide and is a major cause of chronic liver disease. Its transmission in medical facilities is a topic of increased concern, as outbreaks of the disease had raised the attention of media and medical authorities. To date, evidence suggests that infection from in which a health-care worker is involved is mostly result of bad injecting practices as well as the result of shared medical devices. Furthermore, the infection caused by physicians is rare and very few well documented cases exist on the literature. Among countries, different definitions and legislation exist, in that mode that the responsibility of this issue almost is an obligation of individual institutions. Nonetheless, Hepatitis C virus transmission in medical facilities is an important source of new cases, and as treatments options are very limited, it’s recommendable that institutions as well as governments implement policies to avoid Hepatitis C spread in a almost fully preventable setting.
Authors and Affiliations
Francisco Bosques-Padilla, Genaro Vázquez-Elizondo, Ana Villaseñor-Todd, Elvira Garza-González, José Gonzalez-Gonzalez, Héctor Maldonado-Garza
Keywords
Related Articles
- EP ID EP77977
- DOI -
- Views 120
- Downloads 0
Persistent hepatic encephalopathy secondary to portosystemic shunt occluded with Amplatzer device
Hepatic encephalopathy is a frequent complication of cirrhosis, when this event becomes persistent, treatment compliance should be verified and any precipitating factor need to be identified. Also the presence of portosy...
Diastolic dysfunction is associated with low urinary sodium excretion in patients with decompensated cirrhosis
Background/Aim. The pathogenesis and the clinical impact of diastolic dysfunction (DD) in cirrhosis remain unclear. Our aim wasto investigate the factors significantly associated with the presence of DD in patients with...
Visceral adipose tissue visfatin in nonalcoholic fatty liver disease
Background. Visfatin is a novel adipocytokine predominantly expressed and secreted by visceral adipose tissue. It is realized for its multiple functions of central importance in NAD biosynthesis, innate immunity and infl...
The effect of ursodeoxycholic acid in cystic cholangiopathies
Algorithm for Screening of Adrenal Function in Stable Patients with Cirrhosis
Introduction and aims. Adrenal insufficiency (AI) is common in patients with cirrhosis. We aimed to assess the presence of AI in stable patients with cirrhosis using the gold-standard insulin tolerance test (ITT) and to...